Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Latest filing published 03 Dec 2025 for Trevi Therapeutics, Inc., €1,860.
Insider track record
Disclosed buys
0
Disclosed sells
3
Signal history
Christopher Galletta: trading record in brief
Christopher Galletta discloses dealings in 2 companies, chiefly Transact Technologies Inc and Trevi Therapeutics, Inc. The record holds 10 filings, for trades running from 12 November 2010 to 2 December 2025.
On the market, this insider has only sold: 3 sales, €18k in total. Outside the open market, there are 7 option exercises.
The newest entry dates from 3 December 2025: an option exercise of €1,860, in Trevi Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Christopher Galletta
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
4,225 shares@ US$0.51120.3% of flowCommon StockSEC:0001193125-25-306729:0
15,000 shares@ US$0.51179.7% of flowCommon StockSEC:0000950170-24-137255:0
500 shares@ US$2.18Common StockSEC:0001486099-12-000001:0
250 shares@ US$12.87Common StockSEC:0001486099-11-000001:0
500 shares@ US$5.24Common StockSEC:0001486099-11-000001:1
100 shares@ US$2.18Common StockSEC:0001486099-11-000001:2
600 shares@ US$12.43Common StockSEC:0001486099-11-000001:3
1,000 shares@ US$5.24Common StockSEC:0001245706-10-000014:0
600 shares@ US$2.18Common StockSEC:0001245706-10-000014:1
1,600 shares@ US$9.18Common StockSEC:0001245706-10-000014:2
10 of 10 declarations
